Pan-Trk immunoexpression in a superficial malignant ossifying fibromyxoid tumor with ZC3H7B-BCOR fusion: A potential obfuscating factor in the era of targeted therapy.
Konstantinos D LinosDarcy A KerrJanos SumegiJulia A BridgePublished in: Journal of cutaneous pathology (2020)